10.3205/13DGNC318
Schindler, Genevieve
Genevieve
Schindler
Capper, David
David
Capper
Schmieder, Kirsten
Kirsten
Schmieder
Brenke, Christopher
Christopher
Brenke
Distribution of current prognostic factors in long-term surviving glioblastoma patients. A single center retrospective analysis
German Medical Science GMS Publishing House
2013
ConferencePaper
Glioblastoma
Long term survival
Prognosis
610 Medical sciences; Medicine
Deutsche Gesellschaft Für Neurochirurgie
2013-05-21
2013
en
urn:nbn:de:0183-13dgnc3181
13dgnc318
text/html
64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Objective: Despite improved treatment regimes for Glioblastoma patients, the median overall survival (OS) remains poor at 12–15 months. Over the last decade molecular and therapeutic prognostic factors have been described. The clinical implication of these factors is subject of ongoing trials.[for full text, please go to the a.m. URL]
64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)